Impact of acquired immunodeficiency in dermatomycosis. Cases and controls study


  • Carnovale S UAI
  • Relloso S
  • Bendezu K
  • Da Fonseca Scravoni R
  • Lopez Daneri G
  • Grzona E



Dermatomycoses, Human Immunodeficiency Virus, epidemiology


Background: In the population of HIV-infected patients, superficial mycoses may have different clinical manifestations, evolution and etiology from those found in the non-HIV population. Objectives: To describe superficial lesions of fungal etiology in HIV-infected patients and compare them with a control group. Materials and methods: 79 patients (25 HIV positive and 54 controls) were evaluated. A card was prepared with data: age, sex, description and location of the lesion, evolution time and previous treatment. Samples of skin and lines of lesions with suspected fungal etiology were taken and a mycological study was performed. Results: A slightly significant difference was observed between HIV reactive patients with respect to the control group in the number of cases of foot Tinea unguium. The clinical presentation of intertrigo was more observed in the group of HIV positive patients. Conclusions: Superficial mycoses are more common infections in HIV reactive patients, with mixed clinical presentations and the difference in CD4 count between the HIV population in successful ARV treatment does not modify the clinical presentation of dermatophytosis.


Download data is not yet available.


Kumar V, Abbas A K, Aster J C. Robbins y Cotran. Patología Estructural y Funcional.9ª edición. Barcelona, España, 2015. p 243-256.

Navarrete-Dechent C, Ortega R, Fich F, Concha M. Dermatologic manifestations associated with HIV/AIDS. Rev. chil. infectol. 2015, vol.32, suppl.1, pp.57-71.

Mbuagbaw J, Eyong I, Alemnji G, Mpoudi N, Same-Ekobo A. Patterns of skin manifestations and their relationships with CD4 counts among HIV/ AIDS patients in Cameroon. Int J Dermatol 2006; 45: 280-4.

Cedeno-Laurent F, Gómez-Flores M, Méndez N, Ancer-Rodríguez J, Bryant J L, Gaspari A A, et al. New insights into HIV-1primary skin disorders. J Int AIDS Soc 2011; 14: 5.

Aftergut K, Cockerell CJ. Update on the cutaneous manifestations of HIV infection:

clinical and pathologic features. Dermatol Clin 1999; 17: 443-72.

da Silva Bosco C, Claudete Rodrigues P, Ereno Auler M ,da Silva Ruiz L, dos Santos J, Yoshioka M,Fabris A. Dermatophytosis and immunovirological status of HIV‐infected and AIDS patients from Sao Paulo city, Brazil. Mycoses 2014; 57:371-376

Murray Patrick R, Rosenthal Ken S, Pfaller. Microbiología Médica. 7ª edición. Barcelona, España: Elsevier, 2014. p 610-616.

Costa JE, Neves RP, Delgado MM, Lima-Neto RG, Morais VM, Coêlho MR. Dermatophytosis in patients with human immunodeficiency virus infection: clinical aspects and etiologic agents.Acta Trop. 2015 Oct; 150:111-5.

Pussetto, V; Bottinelli,S; Agüero F; Amigot, S; Recarte, M. Dermatofitosis extendida en un paciente con VIH/SIDA. Dermatol Argent 2018, 24(1): 54-56

Toro Giraldo A Cardona N Micosis superficiales en pacientes con VIH/Sida Superficial mycoses in HIV/AIDS patients Revista Asociación Colombiana de Dermatología & Cirugía Dermatológica 832,2019 p 47 a 54

Garza-Garza R, González- Gonzalez S y Ocampo –Candiani J Manifestaciones cutáneas del VIH. Gaceta Médica de México. 2014;150 Suppl 2:194-221

Llahyah Y, Ferrini D, Mercau S, Bulacio L ,Ramadán S, Sortino M, Perafán G y col. Onicomicosis en pacientes con VIH Dermatología Argentina Vol 19,N°1 (2013);VOL XIX N°1 enero febrero




How to Cite

Carnovale S, Relloso S, Bendezu K, Da Fonseca Scravoni R, Lopez Daneri G, Grzona E. Impact of acquired immunodeficiency in dermatomycosis. Cases and controls study. Interamerican Journal of Health Sciences [Internet]. 2021 Dec. 3 [cited 2024 Apr. 25];(1). Available from:



Original Article